Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)

Clinical trial NCT00790205 · COMPLETED

Trial details

NCT number: NCT00790205
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2008-12-10
Primary completion: 2015-03-30
Enrollment: 14671

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.